Celcuity
  • About
    • Overview
    • Our Team
    • Board of Directors
    • Scientific Advisory Board
    • Contact
  • Science
    • PAM Pathway
    • Publications
  • Pipeline
    • Overview
    • Gedatolisib
    • Expanded Access
  • Clinical Trials
    • VIKTORIA-1: Breast Cancer
    • VIKTORIA-2: Breast Cancer
    • CELC-G-201: Prostate Cancer
  • Investors
    • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • SEC Filings
    • Stock Quote
    • Stock Chart
    • Analyst Coverage
    • IR Alerts
  • Careers
    • Overview
    • Culture & Benefits
    • Open Positions

Open Positions


Celcuity logo
16305 36th Avenue North
Minneapolis, MN 55446
Follow us on
in x
©2025 Celcuity Inc.
Privacy PolicyAccessibility Statement